Vegetating nodules following erosions on the oral cavity : a quiz by A.V. Marzano et al.
Acta Derm Venereol 2015; 95: 378–382
QUIZ SECTION
Acta Derm Venereol 95© 2015 The Authors. doi: 10.2340/00015555-1936
Journal Compilation © 2015 Acta Dermato-Venereologica. ISSN 0001-5555
A 68-year-old Italian man presented with a 7-month his-
tory of multiple erosions on the trunk as well as lips and 
oral cavity. Before admission to our department, he was 
treated in another institution with systemic corticosteroids 
(oral prednisone at the initial dose of 1 mg/kg/day, with 
progressively tapering dosages for 2 months) and other 
immunosuppressants, such as azathioprine (1.25 mg/kg/
day for 2 months), intravenous immunoglobulins (one 
cycle consisting of one infusion of 400 mg/kg/day for 5 
consecutive days), and rituximab (one cycle consisting 
of one infusion of 375 mg/m2/every week for 4 weeks), 
achieving resolution of the cutaneous manifestations but 
without control of the oral involvement. Upon admission, 
he had multiple lip and oral erosions (Fig. 1a). In the 
following days, he developed erythematous-violaceous 
vegetating nodules that coalesced into ulcerated plaques 
on the lips and tongue (Fig. 1b). The patient’s general 
condition was compromised; he was asthenic and, due 
to dysphagia, had lost about 15 kg in the last 3 months. 
Staging fibroscopy revealed nodules that induced marked 
stenosis of the larynx and pharynx (Fig. 1c). Within a few 
days, an emergency tracheotomy was required because 
of acute dyspnea. Biopsy specimens from a nodule were 
submitted for histology (Fig. 1d).
What is your diagnosis? See next page for answer.
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Fig. 1. (a) Clinical presentation at the onset: multiple lip and oral erosions. (b) Erythematous-violaceous vegetating nodules that coalesced into ulcerated 
plaques on the lips and tongue. (c) Fibroscopy revealed nodules that induced marked stenosis of the larynx and pharynx. (d) Histopathology: spindle cell 
fascicles, proliferation of irregular blood vessels, focal necrosis and extravasated erythrocytes with release of heamosiderin (H&E; × 25).
2 Quiz: Diagnosis
ANSWERS TO QUIZ
Vegetating Nodules Following Erosions on the Oral 
Cavity: A Comment
Acta Derm Venereol
Diagnosis: Iatrogenic Kaposi’s sarcoma associated 
with pemphigus vulgaris
On admission to our clinic, we confirmed the diagnosis of 
pemphigus vulgaris by means of typical histopathological 
and immunofluorescence features (1).
After few days, during immunosuppressive treatment, 
the oral lesions progressively worsened, and he developed 
erythematous-violaceous nodules.
Histopathologic examination revealed the presence of 
spindle cell fascicles, proliferation of irregular blood ves-
sels, focal necrosis and extravasated erythrocytes with re-
lease of haemosiderin (Fig. 1d). These findings combined 
with strong and diffuse immunohistochemical positivity 
for human herpes virus 8 (HHV8) (Novocastra, UK) were 
consistent with the diagnosis of Kaposi sarcoma (KS). 
Serology for HHV8 was positive, while HIV-1 serum 
antibodies were negative. Therapy based on bleomycin (15 
IU i.m. every 3 weeks) was started in combination with 
corticosteroid tapering. This improved the KS lesions, 
but led to recurrence of pemphigus vulgaris blistering 
lesions; moreover, pancytopenia occurred (white blood 
cell count 1,580 × 109/l [4.8–10.8], platelet count 33 × 109/l 
[150–450]). The patient died one month later after deve-
loping pneumonia sustained by Acinetobacter baumannii 
and subsequent septic shock with multi-organ failure.
KS is an HHV8-associated angioproliferative disorder 
of low-grade malignant potential (2). Aetiopathogenesis is 
still debated, but it is well known that impaired immunity 
could favour the development of this disease. Four types 
of KS are recognised: classic, endemic, iatrogenic and 
AIDS-associated (3). Iatrogenic KS has been observed 
in patients who receive immunosuppressive therapy for 
malignant processes such as lymphomas and multiple 
myeloma, for renal and cardiac transplant recipients, and 
for autoimmune diseases (4–6). Concerning immune-
mediated inflammatory skin conditions, a case of KS 
arising in the context of atopic dermatitis treated with 
cyclosporine has recently been reported (7). KS associated 
with pemphigus is regarded as iatrogenic, and arises after 
the administration of immunosuppressive therapy. The 
clinical features are different from those of the classical 
KS but similar to the AIDS-associated KS: widespread 
lesions with a marked tendency to visceral involvement, 
particularly of the gastrointestinal tract, that often lead to 
death (7, 8). The overall prognosis in a published review of 
10 cases was poor: 5 of the 10 reported cases died within 
1 year from the diagnosis (8–10).
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